The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Phase II Trial of Stereotactic Body Radiation Therapy Combined With Erlotinib for Patients With Limited but Progressive Metastatic Non–Small-Cell Lung Cancer
Abstract
Purpose: Patients with stage IV non–small-cell lung cancer (NSCLC) who progress through first-line therapy have poor progression-free survival (PFS) and overall survival (OS), most commonly failing in original sites of gross disease. Cytoreduction with stereotactic body radiation therapy (SBRT) may help systemic agents delay relapse. Patients and Methods: Patients in our single arm phase II study had stage IV NSCLC with no more than six sites of extracranial disease who failed early systemic chemotherapy and were able to receive SBRT and concurrent erlotinib until disease progression. After erlotinib commencement, SBRT with equipotent fractionation was delivered to all sites of disease. PFS, OS, and other end points were evaluated. Results: Twenty-four patients (13 men and 11 women) with a median age of 67 years (range, 56-86 years) were enrolled with median follow-up of 11.6 months. All patients had progressed through platinum-based chemotherapy. A total of 52 sites were treated with 16 of 24 patients receiving SBRT to more than one site. Lung parenchyma was most often irradiated. Median PFS was 14.7 months, and median OS was 20.4 months. Most patients progressed in new distant sites with only three of 47 measurable lesions recurring within the SBRT field. Two grade 3 toxicities were radiation related. Zero of 13 patients tested were positive for an EGFR mutation. Conclusion: Use of SBRT with erlotinib for unselected patients with stage IV NSCLC as a second- or subsequent line therapy resulted in dramatic changes in patterns of failure, was well tolerated, and resulted in high PFS and OS, substantially greater than historical values for patients who only received systemic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Shepherd, F. A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E. H., Hirsh, V., Thongprasert, S., Campos, D., Maoleekoonpiroj, S., Smylie, M., Martins, R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050753 · Cited by 5,419
Hellman, S., & Weichselbaum, R. R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.8 · Cited by 2,562
Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
Timmerman, R. (2010) · JAMA · doi:10.1001/jama.2010.261 · Cited by 2,532
Self-citationTreatment of Stage I and II Non-small Cell Lung Cancer
Howington, J. A., Blum, M. G., Chang, A. C., Balekian, A. A., & Murthy, S. C. (2013) · Chest · doi:10.1378/chest.12-2359 · Cited by 1,440
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
Rusthoven, K. E., Kavanagh, B. D., Burri, S. H., Chen, C., Cardenes, H., Chidel, M. A., Pugh, T. J., Kane, M., Gaspar, L. E., & Schefter, T. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6386 · Cited by 1,082
Self-citationWeichselbaum, R. R., & Hellman, S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.44 · Cited by 945
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases
Rusthoven, K. E., Kavanagh, B. D., Cardenes, H., Stieber, V. W., Burri, S. H., Feigenberg, S. J., Chidel, M. A., Pugh, T. J., Franklin, W., Kane, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6329 · Cited by 805
Self-citationWeickhardt, A. J., Scheier, B., Burke, J. M., Gan, G., Lu, X., Bunn, P. A., Aisner, D. L., Gaspar, L. E., Kavanagh, B. D., Doebele, R. C., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182745948 · Cited by 684
Self-citationPark, C., Papiez, L., Zhang, S., Story, M., & Timmerman, R. D. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.10.059 · Cited by 651
Self-citationStereotactic body radiotherapy for oligometastases
Tree, A. C., Khoo, V. S., Eeles, R. A., Ahmed, M., Dearnaley, D. P., Hawkins, M. A., Huddart, R. A., Nutting, C. M., Ostler, P. J., & van As, N. J. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70510-7 · Cited by 524
Milano, M. T., Katz, A. W., Zhang, H., & Okunieff, P. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.08.036 · Cited by 439
Stereotactic body radiation therapy: a novel treatment modality
Lo, S. S., Fakiris, A. J., Chang, E. L., Mayr, N. A., Wang, J. Z., Papiez, L., Teh, B. S., McGarry, R. C., Cardenes, H. R., & Timmerman, R. D. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.188 · Cited by 419
Self-citationSystemic Chemotherapy for Advanced Non-Small Cell Lung Cancer: Recent Advances and Future Directions
Ramalingam, S., & Belani, C. (2008) · The Oncologist · doi:10.1634/theoncologist.13-s1-5 · Cited by 333
Salama, J. K., Hasselle, M. D., Chmura, S. J., Malik, R., Mehta, N., Yenice, K. M., Villaflor, V. M., Stadler, W. M., Hoffman, P. C., Cohen, E. E. W., et al. (2012) · Cancer · doi:10.1002/cncr.26611 · Cited by 320
Palma, D. A., Haasbeek, C. J. A., Rodrigues, G. B., Dahele, M., Lock, M., Yaremko, B., Olson, R., Liu, M., Panarotto, J., Griffioen, G., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-305 · Cited by 302
Ashworth, A., Rodrigues, G., Boldt, G., & Palma, D. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.07.026 · Cited by 282
Gan, G. N., Weickhardt, A. J., Scheier, B., Doebele, R. C., Gaspar, L. E., Kavanagh, B. D., & Camidge, D. R. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.11.010 · Cited by 221
Self-citationThe Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens
Simon, R., & Norton, L. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0560 · Cited by 207
Treatment of Stage IV Non-small Cell Lung Cancer
Socinski, M. A., Evans, T., Gettinger, S., Hensing, T. A., VanDam Sequist, L., Ireland, B., & Stinchcombe, T. E. (2013) · Chest · doi:10.1378/chest.12-2361 · Cited by 189
Rusthoven, K. E., Hammerman, S. F., Kavanagh, B. D., Birtwhistle, M. J., Stares, M., & Camidge, D. R. (2009) · Acta Oncologica · doi:10.1080/02841860802662722 · Cited by 165
Self-citationGriffioen, G. H. M. J., Toguri, D., Dahele, M., Warner, A., de Haan, P. F., Rodrigues, G. B., Slotman, B. J., Yaremko, B. P., Senan, S., & Palma, D. A. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.07.023 · Cited by 158
Radiation sensitivity of human lung cancer cell lines
Carmichael, J., DeGraff, W., Gamson, J., Russo, D., Gazdar, A. F., Levitt, M. L., Minna, J. D., & Mitchell, J. B. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90266-6 · Cited by 157
Ito, K., Govindarajan, A., Ito, H., & Fong, Y. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181d7e8e5 · Cited by 106
Hasselle, M. D., Haraf, D. J., Rusthoven, K. E., Golden, D. W., Salgia, R., Villaflor, V. M., Shah, N., Hoffman, P. C., Chmura, S. J., Connell, P. P., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824166a5 · Cited by 101
Surgical management of adrenal metastases
Sancho, J., Triponez, F., Montet, X., & Sitges‐Serra, A. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0889-1 · Cited by 92
Milano, M. T., Philip, A., & Okunieff, P. G. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.073 · Cited by 84
Stereotactic Ablative Radiotherapy for Non–Small Cell Lung Cancer: Rationale and Outcomes
Iyengar, P., & Timmerman, R. D. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0157 · Cited by 48
Self-citationManagement of Non-Small Cell Lung Cancer with Oligometastasis
Villaruz, L. C., Kubicek, G. J., & Socinski, M. A. (2012) · Current Oncology Reports · doi:10.1007/s11912-012-0240-1 · Cited by 47
Surgical management of adrenal metastases
Bradley, C. T., & Strong, V. E. M. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23461 · Cited by 46
Stereotactic body radiotherapy treatment of extracranial metastases
Salama, J. K., Kirkpatrick, J. P., & Yin, F.-F. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.166 · Cited by 41
Third CECOG consensus on the systemic treatment of non-small-cell lung cancer
Brodowicz, T., Ciuleanu, T., Crawford, J., Filipits, M., Fischer, J. R., Georgoulias, V., Gridelli, C., Hirsch, F. R., Jassem, J., Kosmidis, P., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr381 · Cited by 27
Oligometastases: the new paradigm and options for radiotherapy
Badakhshi, H., Grün, A., Stromberger, C., Budach, V., & Boehmer, D. (2013) · Strahlentherapie und Onkologie · doi:10.1007/s00066-013-0326-1 · Cited by 24
Stereotactic Body Radiation Therapy for Treatment of Primary and Metastatic Pulmonary Malignancies
Kelsey, C. R., & Salama, J. K. (2013) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2013.02.011 · Cited by 17
Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?
Passaro, A., Cortesi, E., & de Marinis, F. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.120 · Cited by 15
Maintenance Therapy for Advanced Lung Cancer: Who, What, and When?
Gerber, D. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5201 · Cited by 13
Self-citationTassinari, D., Scarpi, E., Sartori, S., Drudi, F., Castellani, C., Carloni, F., Tombesi, P., & Lazzari-Agli, L. (2011) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31822dfd13 · Cited by 9
Cited by
Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J., Chirieac, L. R., D'Amico, T. A., DeCamp, M. M., Dilling, T. J., Dobelbower, M., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0050 · Cited by 1,303
Self-citationGuckenberger, M., Lievens, Y., Bouma, A. B., Collette, L., Dekker, A., deSouza, N. M., Dingemans, A.-M. C., Fournier, B., Hurkmans, C., Lecouvet, F. E., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30718-1 · Cited by 1,111
Gomez, D. R., Blumenschein, G. R., Lee, J. J., Hernandez, M., Ye, R., Camidge, D. R., Doebele, R. C., Skoulidis, F., Gaspar, L. E., Gibbons, D. L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30532-0 · Cited by 1,086
Self-citationIyengar, P., Wardak, Z., Gerber, D. E., Tumati, V., Ahn, C., Hughes, R. S., Dowell, J. E., Cheedella, N., Nedzi, L., Westover, K. D., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3501 · Cited by 1,047
Self-citationRingel, M. D., Sosa, J. A., Baloch, Z., Bischoff, L., Bloom, G., Brent, G. A., Brock, P. L., Chou, R., Flavell, R. R., Goldner, W., et al. (2025) · Thyroid® · doi:10.1177/10507256251363120 · Cited by 710
Metadata
- Authors
- Iyengar, P., Kavanagh, B. D., Wardak, Z., Smith, I., Ahn, C., Gerber, D. E., Dowell, J., Hughes, R., Abdulrahman, R., Camidge, D. R., Gaspar, L. E., Doebele, R. C., Bunn, P. A., Choy, H., & Timmerman, R.
- Venue
- Journal of Clinical Oncology
- Published
- 2014-12-01
- Volume
- 32
- Issue
- 34
- Pages
- 3824-3830
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2137602317
- Cited by
- 286
- References
- 37
- FWCI
- 24.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.